[Austrian Consensus on High Blood Pressure 2019].

[1]  J. Auer,et al.  Blood pressure changes after renal denervation are more pronounced in women and nondiabetic patients: findings from the Austrian Transcatheter Renal Denervation Registry. , 2019, Journal of hypertension.

[2]  T. Weber,et al.  High prevalence of hypertension and early vascular aging: a screening program in pharmacies in Upper Austria , 2019, Journal of Human Hypertension.

[3]  W. E. Sanabria,et al.  Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial , 2019, The Lancet.

[4]  M. Weir,et al.  Hypertension in CKD: Core Curriculum 2019. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  M. Burnier,et al.  Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis. , 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  A. Kirtane,et al.  Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control Following Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial. , 2019, Circulation.

[7]  J. Butler,et al.  Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study. , 2019, Clinical journal of the American Society of Nephrology : CJASN.

[8]  A. Stein,et al.  Factors Associated With High-Quality Guidelines for the Pharmacologic Management of Chronic Diseases in Primary Care: A Systematic Review , 2019, JAMA internal medicine.

[9]  G. Twig,et al.  Association of Adolescent Hypertension With Future End-stage Renal Disease , 2019, JAMA internal medicine.

[10]  N. Poulter,et al.  May Measurement Month 2017: an analysis of blood pressure screening results in Austria—Europe , 2019, European heart journal supplements : journal of the European Society of Cardiology.

[11]  N. Dhaun,et al.  Management of Hypertension in Chronic Kidney Disease , 2019, Drugs.

[12]  J. Williamson,et al.  Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial , 2019, JAMA.

[13]  A. Ortiz,et al.  Multilayered Interplay Between Fructose and Salt in Development of Hypertension: What Has Been Revealed So Far , 2019, Hypertension.

[14]  David W. Johnson,et al.  Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. , 2019, Kidney international.

[15]  M. Evans,et al.  The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease , 2019, BMC Nephrology.

[16]  Declare–Timi Investigators.  Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes , 2019 .

[17]  Chun-Peng Liu,et al.  Improving outcomes in chronic obstructive pulmonary disease by taking beta-blockers after acute myocardial infarction: a nationwide observational study , 2019, Heart and Vessels.

[18]  C. Gallo,et al.  Generalizability of SPRINT-CKD cohort to CKD patients referred to renal clinics , 2019, Journal of Nephrology.

[19]  J. Hallas,et al.  Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin‐converting enzyme inhibitors – a nationwide registry‐based cohort study , 2019, Journal of internal medicine.

[20]  S. M. Park,et al.  Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial. , 2019, Lancet.

[21]  M. Rocco,et al.  Use of Renin-Angiotensin System Blockade in Advanced CKD: An NKF-KDOQI Controversies Report. , 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  L. Appel,et al.  Blood Pressure Goals in Patients with CKD: A Review of Evidence and Guidelines. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[23]  R. Agarwal,et al.  Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[24]  Mian Peng,et al.  Comparative efficacy of individual renin–angiotensin system inhibitors on major renal outcomes in diabetic kidney disease: a network meta-analysis , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  F. Beuschlein,et al.  Update endokrine Hypertonie , 2018, Der Internist.

[26]  A. Evangelista,et al.  Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome. , 2018, Journal of the American College of Cardiology.

[27]  Thomas Kahan,et al.  [2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]. , 2018, Giornale italiano di cardiologia.

[28]  C. McCulloch,et al.  Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers , 2018, Journal of the American Heart Association.

[29]  W. Young,et al.  Diagnosis and treatment of primary aldosteronism: practical clinical perspectives , 2018, Journal of internal medicine.

[30]  F. Prischl,et al.  Gelingende Kommunikation mit Hypertonikern // Successful communication with hypertensive patients , 2018 .

[31]  G. Lip,et al.  ESC Council on hypertension position document on the management of hypertensive emergencies. , 2018, European heart journal. Cardiovascular pharmacotherapy.

[32]  G. Lip,et al.  2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.

[33]  Susanna Price,et al.  2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. , 2018, European heart journal.

[34]  G. Adler,et al.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment. , 2018, Endocrine reviews.

[35]  R. Kloner,et al.  Effect of Patiromer in Hyperkalemic Patients Taking and Not Taking RAAS Inhibitors , 2018, Journal of cardiovascular pharmacology and therapeutics.

[36]  K. Mu,et al.  Effect of Levothyroxine on Blood Pressure in Patients With Subclinical Hypothyroidism: A Systematic Review and Meta-Analysis , 2018, Front. Endocrinol..

[37]  R. Hermida,et al.  Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for prevention , 2018, European heart journal.

[38]  G. Parati,et al.  Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 13 – benefits and adverse events in older and younger patients with hypertension overview, meta-analyses and meta-regression analyses of randomized trials , 2018, Journal of hypertension.

[39]  P. Chanson,et al.  A Consensus Statement on acromegaly therapeutic outcomes , 2018, Nature Reviews Endocrinology.

[40]  S. Pearce,et al.  2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism , 2018, European Thyroid Journal.

[41]  U. Heemann,et al.  Association of Ambulatory Blood Pressure with All-Cause and Cardiovascular Mortality in Hemodialysis Patients: Effects of Heart Failure and Atrial Fibrillation. , 2018, Journal of the American Society of Nephrology : JASN.

[42]  George Thomas,et al.  BP Measurement Techniques: What They Mean for Patients with Kidney Disease. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[43]  R. Unwin,et al.  Liquorice, Liddle, Bartter or Gitelman-how to differentiate? , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[44]  P. Ponikowski,et al.  Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology , 2018, European heart journal. Cardiovascular pharmacotherapy.

[45]  Patrick Taffé,et al.  Sodium intake and blood pressure in children and adolescents: a systematic review and meta-analysis of experimental and observational studies. , 2018, International journal of epidemiology.

[46]  T. Weber,et al.  Pulsatile arterial haemodynamics in heart failure. , 2018, European heart journal.

[47]  J. Martínez,et al.  Retraction and Republication: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 2013;368:1279-90. , 2018, The New England journal of medicine.

[48]  J. Auer,et al.  J-curves in hypertension: what do they tell us about treatment of high blood pressure? , 2018, European heart journal.

[49]  Sungha Park,et al.  Antihypertensive Treatment in Severe Aortic Stenosis , 2018, Journal of cardiovascular imaging.

[50]  S. Pocock,et al.  Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial , 2018, The Lancet.

[51]  D. Webb,et al.  Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies , 2018, The lancet. Diabetes & endocrinology.

[52]  L. Nieman.  Diagnosis of Cushing's Syndrome in the Modern Era. , 2018, Endocrinology and metabolism clinics of North America.

[53]  Neil Chapman,et al.  Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial , 2018, The Lancet.

[54]  M. Freeman,et al.  Long‐term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin‐converting enzymes/angiotensin receptor blockers: results from AMETHYST‐DN , 2018, ESC heart failure.

[55]  Jackson T. Wright,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American College of Cardiology.

[56]  P. Whelton,et al.  Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial) , 2018, Hypertension.

[57]  C. Wanner,et al.  Renal Outcomes of Antidiabetic Treatment Options for Type 2 Diabetes—A Proposed MARE Definition , 2018, Kidney international reports.

[58]  José R. Banegas,et al.  Relationship between Clinic and Ambulatory Blood‐Pressure Measurements and Mortality , 2018, The New England journal of medicine.

[59]  V. Papademetriou,et al.  Attended and Unattended Automated Office Blood Pressure Measurements Have Better Agreement With Ambulatory Monitoring Than Conventional Office Readings , 2018, Journal of the American Heart Association.

[60]  J. Eckstein,et al.  Reliability of single office blood pressure measurements , 2018, Heart.

[61]  Karim Ladha,et al.  Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial , 2018, The Lancet.

[62]  P. Fornara,et al.  Influence of SPRINT Study Type Automated Office Blood Pressure Measurements on Hypertension Diagnosis in Kidney Transplant Patients , 2018, Kidney and Blood Pressure Research.

[63]  P. Kalra,et al.  The effect of revascularization in patients with anatomically significant atherosclerotic renovascular disease presenting with high-risk clinical features , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[64]  Alan Murray,et al.  A universal standard for the validation of blood pressure measuring devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statement. , 2018, Journal of hypertension.

[65]  X. Jeunemaître,et al.  Liddle Syndrome: Review of the Literature and Description of a New Case , 2018, International journal of molecular sciences.

[66]  A. Vaidya,et al.  The Low-Renin Hypertension Phenotype: Genetics and the Role of the Mineralocorticoid Receptor , 2018, International journal of molecular sciences.

[67]  C. Redman,et al.  Meta-Analysis and Systematic Review to Assess the Role of Soluble FMS-Like Tyrosine Kinase-1 and Placenta Growth Factor Ratio in Prediction of Preeclampsia: The SaPPPhirE Study , 2018, Hypertension.

[68]  V. Calice-Silva,et al.  Sodium Intake and Blood Pressure in Patients with Chronic Kidney Disease: A Salty Relationship , 2018, Blood Purification.

[69]  G. Filippatos,et al.  Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease , 2018, ESC heart failure.

[70]  G. Mancia,et al.  Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach , 2018, Diabetologia.

[71]  P. Whelton,et al.  Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control , 2018, Circulation.

[72]  Marco Valgimigli,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[73]  A. Pottegård,et al.  Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case‐control study from Denmark , 2017, Journal of the American Academy of Dermatology.

[74]  W. März,et al.  Primärer Hyperaldosteronismus: Diagnostik und Therapie , 2017, Journal für Klinische Endokrinologie und Stoffwechsel.

[75]  S. Minisola,et al.  Cardiovascular manifestations of primary hyperparathyroidism: a narrative review. , 2017, European journal of endocrinology.

[76]  P. Libby,et al.  Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial , 2017, European heart journal.

[77]  M. Tetti,et al.  Is Primary Aldosteronism Still Largely Unrecognized? , 2017, Hormone and Metabolic Research.

[78]  Neil Chapman,et al.  Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial , 2017, The Lancet.

[79]  P. Heuschmann,et al.  Control of cardiovascular risk factors and its determinants in the general population– findings from the STAAB cohort study , 2017, BMC Cardiovascular Disorders.

[80]  G. Parati,et al.  Effects of blood-pressure-lowering treatment on outcome incidence. 12. Effects in individuals with high-normal and normal blood pressure: overview and meta-analyses of randomized trials , 2017, Journal of hypertension.

[81]  D. Webb,et al.  Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double‐Blind Randomized Controlled Trial , 2017, Journal of the American Heart Association.

[82]  G. Parati,et al.  Effects of blood-pressure-lowering treatment on outcome incidence in hypertension. 11. Effects of total cardiovascular risk and achieved blood pressure: overview and meta-analyses of randomized trials , 2017, Journal of hypertension.

[83]  J. Ix,et al.  BP Measurement in Clinical Practice: Time to SPRINT to Guideline-Recommended Protocols. , 2017, Journal of the American Society of Nephrology : JASN.

[84]  S. Jaber,et al.  Effect of Individualized vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major Surgery: A Randomized Clinical Trial , 2017, JAMA.

[85]  G. Mancia,et al.  Cardiovascular Risk Associated With White-Coat Hypertension: Pro Side of the Argument. , 2017, Hypertension.

[86]  R. Holman,et al.  Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis , 2017, JAMA internal medicine.

[87]  J. Hallas,et al.  Hydrochlorothiazide use is strongly associated with risk of lip cancer , 2017, Journal of internal medicine.

[88]  William L. Baker,et al.  Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of the ACCORD-BP Trial , 2017 .

[89]  A. Delitala.  Subclinical Hyperthyroidism and the Cardiovascular Disease , 2017, Hormone and Metabolic Research.

[90]  Jackson T. Wright,et al.  Effects of Intensive BP Control in CKD. , 2017, Journal of the American Society of Nephrology : JASN.

[91]  W. Young,et al.  Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. , 2017, The lancet. Diabetes & endocrinology.

[92]  N. Samani,et al.  Biochemical Screening for Nonadherence Is Associated With Blood Pressure Reduction and Improvement in Adherence , 2017, Hypertension.

[93]  James R. Powell,et al.  Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial , 2017, Diabetes Care.

[94]  T. Ninomiya,et al.  Day-to-Day Blood Pressure Variability and Risk of Dementia in a General Japanese Elderly Population , 2017, Circulation.

[95]  S. Haulon,et al.  Impact of the Management of Type B Aortic Dissection on the Long-Term Blood Pressure. , 2017, The American journal of cardiology.

[96]  Pavel S. Roshanov,et al.  Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort , 2017, Anesthesiology.

[97]  A. Cremer,et al.  Accuracy of Cuff-Measured Blood Pressure: Systematic Reviews and Meta-Analyses. , 2017, Journal of the American College of Cardiology.

[98]  G. Mancia,et al.  Protective effects of antihypertensive treatment in patients aged 85 years or older , 2017, Journal of hypertension.

[99]  Nicola Persico,et al.  Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia , 2017, The New England journal of medicine.

[100]  Luxi Cao,et al.  Comparison of thiazide‐like diuretics versus thiazide‐type diuretics: a meta‐analysis , 2017, Journal of cellular and molecular medicine.

[101]  K. Mahaffey,et al.  Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes , 2017, The New England journal of medicine.

[102]  R. Zietse,et al.  Chlorthalidone Versus Amlodipine for Hypertension in Kidney Transplant Recipients Treated With Tacrolimus: A Randomized Crossover Trial. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[103]  G. Lip,et al.  Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiologí , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[104]  F. Prischl,et al.  Nierenarterienstenose und ischämische Nierenerkrankungen – eine Übersicht // Renal artery stenosis and ischemic kidney disease – a review , 2017 .

[105]  G. Parati,et al.  Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 – Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials , 2017, Journal of hypertension.

[106]  P. Chanson,et al.  Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN. , 2017, European journal of endocrinology.

[107]  Dave L Dixon,et al.  Effects of Sodium‐Glucose Cotransporter 2 Inhibitors on 24‐Hour Ambulatory Blood Pressure: A Systematic Review and Meta‐Analysis , 2017, Journal of the American Heart Association.

[108]  P. Dong,et al.  A meta-analysis of add-on use of spironolactone in patients with resistant hypertension. , 2017, International journal of cardiology.

[109]  A. Rahmim,et al.  Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition , 2017, JAMA.

[110]  A. Dominiczak,et al.  Genomics and Precision Medicine for Clinicians and Scientists in Hypertension. , 2017, Hypertension.

[111]  W. Young,et al.  Screening for Endocrine Hypertension: An Endocrine Society Scientific Statement , 2017 .

[112]  G. Bakris,et al.  Sustained Reduction of Blood Pressure With Baroreceptor Activation Therapy: Results of the 6-Year Open Follow-Up , 2017, Hypertension.

[113]  K. Bhaskaran,et al.  Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study , 2017, British Medical Journal.

[114]  S. Yusuf,et al.  Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes. , 2017, Kidney international.

[115]  H. Willenberg.  How to Escape from Primary Aldosteronism? News and Views on an Adrenal Disorder of Salt Retention , 2017, Hormone and Metabolic Research.

[116]  G. de Simone,et al.  Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network) , 2017, Journal of the American Heart Association.

[117]  S. Bangalore,et al.  Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients. , 2017, Journal of the American College of Cardiology.

[118]  D. Calhoun,et al.  Use of Aldosterone Antagonists for Treatment of Uncontrolled Resistant Hypertension , 2017, American journal of hypertension.

[119]  J. Funder.  Apparent mineralocorticoid excess , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[120]  M. Yau,et al.  Apparent mineralocorticoid excess and the long term treatment of genetic hypertension , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[121]  S. Pilz.  Nebenniereninsuffizienz und Nebenniereninzidentalome , 2017, Wiener klinische Wochenschrift Education.

[122]  Ivy Shiue,et al.  Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015 , 2017, JAMA.

[123]  M. Marazuela,et al.  Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management , 2017, Endocrine.

[124]  P. Kirchhof,et al.  [2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS]. , 2016, Kardiologia polska.

[125]  Anita Deswal,et al.  Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. , 2016, Circulation.

[126]  Sudha Seshadri,et al.  Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association , 2016, Hypertension.

[127]  C. Cannon,et al.  Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication , 2016, Hypertension.

[128]  J. Funder.  Primary aldosteronism as a public health issue. , 2016, The lancet. Diabetes & endocrinology.

[129]  Morris J. Brown,et al.  Primary aldosteronism as a public health issue - Authors' reply. , 2016, The lancet. Diabetes & endocrinology.

[130]  P. López-Jaramillo,et al.  A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension , 2016, The Lancet.

[131]  Joseph M Pappachan,et al.  Endocrine Hypertension: A Practical Approach. , 2016, Advances in experimental medicine and biology.

[132]  R. Cífková,et al.  Threshold for diagnosing hypertension by automated office blood pressure using random sample population data , 2016, Journal of hypertension.

[133]  B. Krämer,et al.  Minoxidil for Treatment of Resistant Hypertension in Chronic Kidney Disease––A Retrospective Cohort Analysis , 2016, Journal of clinical hypertension.

[134]  N. Karavitaki,et al.  Epidemiology of acromegaly: review of population studies , 2016, Pituitary.

[135]  A. Hoes,et al.  2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. , 2016, European heart journal.

[136]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[137]  J. Singer,et al.  The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study) , 2016, Hypertension.

[138]  A. Dominiczak,et al.  Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders , 2016, Hypertension.

[139]  S. Rivkees,et al.  2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. , 2016, Thyroid : official journal of the American Thyroid Association.

[140]  G. Parati,et al.  Effects of blood-pressure-lowering treatment in hypertension: 9. Discontinuations for adverse events attributed to different classes of antihypertensive drugs meta-analyses of randomized trials , 2016, Journal of hypertension.

[141]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[142]  Lawrence A Leiter,et al.  Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. , 2016, The New England journal of medicine.

[143]  W. Spiering,et al.  Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial. , 2016, The lancet. Diabetes & endocrinology.

[144]  V. Beral,et al.  Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents , 2016, The Lancet.

[145]  M. Myers.  A Short History of Automated Office Blood Pressure – 15 Years to SPRINT , 2016, Journal of clinical hypertension.

[146]  G. Lip,et al.  From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency , 2016, Journal of Human Hypertension.

[147]  G. Parati,et al.  Effects of blood pressure lowering treatment in hypertension: 8. Outcome reductions vs. discontinuations because of adverse drug events – meta-analyses of randomized trials , 2016, Journal of hypertension.

[148]  A. Dominiczak,et al.  2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. , 2016, Journal of hypertension.

[149]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[150]  T. Pieber,et al.  Randomized Evaluation of the Effectiveness of a Structured Educational Program for Patients With Essential Hypertension. , 2016, American journal of hypertension.

[151]  K. Huber,et al.  Awareness, treatment, and control of hypertension in Austria: a multicentre cross-sectional study , 2016, Journal of hypertension.

[152]  Lenore J Launer,et al.  Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial. , 2016, JAMA.

[153]  A. Kaltoft,et al.  Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial , 2016, Journal of hypertension.

[154]  John B Buse,et al.  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. , 2016, The New England journal of medicine.

[155]  R. Zweiker,et al.  Hypertension and coronary artery disease: epidemiology, physiology, effects of treatment, and recommendations , 2016, Wiener klinische Wochenschrift.

[156]  Jackson T. Wright,et al.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control. , 2016, The New England journal of medicine.

[157]  D. Hanley,et al.  Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. , 2016, The New England journal of medicine.

[158]  Mark Woodward,et al.  Blood Pressure and Risk of Vascular Dementia: Evidence From a Primary Care Registry and a Cohort Study of Transient Ischemic Attack and Stroke , 2016, Stroke.

[159]  N. Markandu,et al.  Modest Salt Reduction Lowers Blood Pressure and Albumin Excretion in Impaired Glucose Tolerance and Type 2 Diabetes Mellitus: A Randomized Double-Blind Trial , 2016, Hypertension.

[160]  B. Paulweber,et al.  Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications , 2016, Wiener klinische Wochenschrift.

[161]  G. Parati,et al.  Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels – updated overview and meta-analyses of randomized trials , 2016, Journal of hypertension.

[162]  S. Bergese,et al.  Perioperative Use of Clevidipine: A Systematic Review and Meta-Analysis , 2016, PloS one.

[163]  S. Ito,et al.  Effect of Behavior Modification on Outcome in Early- to Moderate-Stage Chronic Kidney Disease: A Cluster-Randomized Trial , 2016, PloS one.

[164]  S. Anderson,et al.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis , 2016, The Lancet.

[165]  W. Young,et al.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[166]  T. Ichiki.  Thyroid Hormone and Vascular Remodeling. , 2016, Journal of atherosclerosis and thrombosis.

[167]  Bo Carlberg,et al.  Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses , 2016 .

[168]  Otto Mayer,et al.  Automated compared to manual office blood pressure and to home blood pressure in hypertensive patients , 2016, Blood pressure.

[169]  F. Messerli,et al.  Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring. , 2016, Journal of the American College of Cardiology.

[170]  Jie Li,et al.  Rare and curable renin-mediated hypertension: a series of six cases and a literature review , 2016, Journal of pediatric endocrinology & metabolism : JPEM.

[171]  Sandosh Padmanabhan,et al.  Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial , 2016, The lancet. Diabetes & endocrinology.

[172]  H. Bae,et al.  Spontaneous Intracerebral Hemorrhage: Management , 2016, Journal of stroke.

[173]  M. Woodward,et al.  Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis , 2016, The Lancet.

[174]  G. Liu,et al.  Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults. , 2016, The Cochrane database of systematic reviews.

[175]  L. Laurin,et al.  Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[176]  A. Morganti,et al.  Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays , 2015, Journal of hypertension.

[177]  R. de Caterina,et al.  Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial , 2015, Journal of the American Heart Association.

[178]  B. Zinman,et al.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2015, The New England journal of medicine.

[179]  Isla Mackenzie,et al.  Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial , 2015, The Lancet.

[180]  G. Mayer,et al.  Diabetes-related end-stage renal disease in Austria 1965-2013. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[181]  S. Bangalore,et al.  Resistant hypertension: what the cardiologist needs to know. , 2015, European heart journal.

[182]  L. Hinton,et al.  The Effect of Self-Monitoring of Blood Pressure on Medication Adherence and Lifestyle Factors: A Systematic Review and Meta-Analysis. , 2015, American journal of hypertension.

[183]  Mark Woodward,et al.  Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults , 2015, BMJ : British Medical Journal.

[184]  F. Messerli,et al.  Drug induced hypertension--An unappreciated cause of secondary hypertension. , 2015, European journal of pharmacology.

[185]  V. Aboyans,et al.  The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. , 2015, Atherosclerosis.

[186]  M. Olsen,et al.  Effective risk stratification in patients with moderate cardiovascular risk using albuminuria and atherosclerotic plaques in the carotid arteries , 2015, Journal of hypertension.

[187]  G. Chatellier,et al.  Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension , 2015, Blood pressure.

[188]  A. Tabarin,et al.  Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. , 2015, The Journal of clinical endocrinology and metabolism.

[189]  J. Saver,et al.  Effect of Blood Pressure Lowering in Early Ischemic Stroke: Meta-Analysis , 2015, Stroke.

[190]  A. Colao,et al.  The Treatment of Cushing's Disease. , 2015, Endocrine reviews.

[191]  Christopher M O'Connor,et al.  Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension , 2015 .

[192]  R. Agarwal,et al.  Thiazides in advanced chronic kidney disease: time for a randomized controlled trial , 2015, Current opinion in cardiology.

[193]  J. Gottdiener,et al.  Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)†. , 2015, European heart journal cardiovascular Imaging.

[194]  G. Parati,et al.  Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs – overview and meta-analyses , 2015, Journal of hypertension.

[195]  J. Schneider,et al.  Vascular contributions to cognitive impairment and dementia including Alzheimer's disease , 2015, Alzheimer's & Dementia.

[196]  J. Staessen,et al.  8B.01: META-ANALYSIS OF FIVE PROSPECTIVE AND RANDOMIZED CONTROLLED TRIALS OF RENAL SYMPATHETIC DENERVATION ON OFFICE AND AMBULATORY SYSTOLIC BLOOD PRESSURE IN TREATMENT RESISTANT HYPERTENSION , 2015, Journal of hypertension.

[197]  M. Tonelli,et al.  Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis , 2015, The Lancet.

[198]  S. Pilz,et al.  Fluconazole and acetazolamide in the treatment of ectopic Cushing's syndrome with severe metabolic alkalosis , 2015, Endocrinology, diabetes & metabolism case reports.

[199]  J. Kostis,et al.  Head-to-Head Comparisons of Hydrochlorothiazide With Indapamide and Chlorthalidone: Antihypertensive and Metabolic Effects , 2015, Hypertension.

[200]  L. Brewster,et al.  Effects of Thiazide-Type and Thiazide-Like Diuretics on Cardiovascular Events and Mortality: Systematic Review and Meta-Analysis , 2015, Hypertension.

[201]  Siegfried Wassertheurer,et al.  Noninvasive methods to assess pulse wave velocity: comparison with the invasive gold standard and relationship with organ damage , 2015, Journal of hypertension.

[202]  Nicolas C. Nicolaides,et al.  Chrousos syndrome: from molecular pathogenesis to therapeutic management , 2015, European journal of clinical investigation.

[203]  M. Uder,et al.  Central pulse pressure predicts BP reduction after renal denervation in patients with treatment-resistant hypertension. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[204]  K. Reynolds,et al.  Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and non-resistant hypertension , 2015, Kidney international.

[205]  E. Seely,et al.  Effects of hormone therapy on blood pressure , 2015, Menopause.

[206]  G. Parati,et al.  Blood Pressure Variability: Assessment, Predictive Value, and Potential as a Therapeutic Target , 2015, Current Hypertension Reports.

[207]  G. Mancia,et al.  Clinical value of ambulatory blood pressure: evidence and limits. , 2015, Circulation research.

[208]  S. Textor,et al.  Management of atherosclerotic renovascular disease after Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL). , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[209]  R. Iliescu,et al.  The Baroreflex as a Long-Term Controller of Arterial Pressure , 2022 .

[210]  S. Hernández-Díaz,et al.  Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study. , 2015, American journal of obstetrics and gynecology.

[211]  A. Althouse,et al.  Uric Acid Determination in Gestational Hypertension , 2015, Reproductive Sciences.

[212]  K. Rahimi,et al.  Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. , 2015, JAMA.

[213]  G. Parati,et al.  Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs – Overview and meta-analyses , 2015, Journal of hypertension.

[214]  L. Mbuagbaw,et al.  Effect of green tea supplementation on blood pressure among overweight and obese adults: a systematic review and meta-analysis , 2015, Journal of hypertension.

[215]  J. Singer,et al.  Less-tight versus tight control of hypertension in pregnancy. , 2015, The New England journal of medicine.

[216]  Deepak L. Bhatt,et al.  Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. , 2015, European heart journal.

[217]  N. Hirawa,et al.  Effects of doxazosin as the third agent on morning hypertension and position-related blood pressure changes in diabetic patients with chronic kidney disease , 2015, Clinical and experimental hypertension.

[218]  M. Böhm,et al.  Reduced Effect of Percutaneous Renal Denervation on Blood Pressure in Patients With Isolated Systolic Hypertension , 2015, Hypertension.

[219]  C. McCulloch,et al.  Blood Pressure and Risk of All-Cause Mortality in Advanced Chronic Kidney Disease and Hemodialysis: The Chronic Renal Insufficiency Cohort Study , 2015, Hypertension.

[220]  Biykem Bozkurt,et al.  2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[221]  D. DeMets,et al.  2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[222]  M. Tonelli,et al.  Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. , 2014, The Cochrane database of systematic reviews.

[223]  G. Parati,et al.  Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials , 2014, Journal of hypertension.

[224]  B. Alpert,et al.  Oscillometric blood pressure: a review for clinicians. , 2014, Journal of the American Society of Hypertension : JASH.

[225]  Anne R Cappola,et al.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. , 2014, Thyroid : official journal of the American Thyroid Association.

[226]  G. Parati,et al.  Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels – overview and meta-analyses of randomized trials , 2014, Journal of hypertension.

[227]  R. Vadhera,et al.  Hypertensive emergencies in pregnancy. , 2014, Clinical obstetrics and gynecology.

[228]  E. Laws,et al.  Acromegaly: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.

[229]  J. Sharman,et al.  Exercise blood pressure: clinical relevance and correct measurement , 2014, Journal of Human Hypertension.

[230]  S. Laurent,et al.  Dose-Dependent Arterial Destiffening and Inward Remodeling After Olmesartan in Hypertensives With Metabolic Syndrome , 2014, HYPERTENSION.

[231]  Martin Schillinger,et al.  Perioperative beta-blockers for preventing surgery-related mortality and morbidity. , 2014, The Cochrane database of systematic reviews.

[232]  T. Weber,et al.  Hypertensiver Notfall - hypertensive Entgleisung (Krise) , 2014 .

[233]  Susanna Price,et al.  2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). , 2014, European heart journal.

[234]  Emma P Bray,et al.  Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. , 2014, JAMA.

[235]  M. Walsh,et al.  Reninoma: An Uncommon Cause of Renin-Mediated Hypertension , 2014, Front. Pediatr..

[236]  K. Kalantar-Zadeh,et al.  Impact of achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population. , 2014, Journal of the American College of Cardiology.

[237]  J. Sowers,et al.  Thyroid and the heart. , 2014, The American journal of medicine.

[238]  D. Thijssen,et al.  The Effect of Black Tea on Blood Pressure: A Systematic Review with Meta-Analysis of Randomized Controlled Trials , 2014, PloS one.

[239]  R. D'Agostino,et al.  Use of renin-angiotensin inhibitors in people with renal artery stenosis. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[240]  Geoffrey A Head,et al.  European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. , 2014, Journal of hypertension.

[241]  R. Lamuela-Raventós,et al.  Mediterranean Diet Reduces 24-Hour Ambulatory Blood Pressure, Blood Glucose, and Lipids: One-Year Randomized, Clinical Trial , 2014, Hypertension.

[242]  P. D. de Leeuw,et al.  European consensus on the diagnosis and management of fibromuscular dysplasia. , 2014, Journal of hypertension.

[243]  W. Young,et al.  Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.

[244]  Brian A Ference,et al.  Clinical Effect of Naturally Random Allocation to Lower Systolic Blood Pressure Beginning Before the Development of Hypertension , 2014, Hypertension.

[245]  Harry Hemingway,et al.  Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people , 2014, The Lancet.

[246]  F. Messerli,et al.  Secondary arterial hypertension: when, who, and how to screen? , 2014, European heart journal.

[247]  S. Bell,et al.  Renal Artery Stenosis—When To Screen, What To Stent? , 2014, Current Atherosclerosis Reports.

[248]  L. Poston,et al.  Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis , 2014, BMJ : British Medical Journal.

[249]  Christopher P Price,et al.  Diagnostic Accuracy of Point-of-Care Tests for Detecting Albuminuria , 2014, Annals of Internal Medicine.

[250]  Deepak L. Bhatt,et al.  Refining calcium test for diagnosis of medullary thyroid cancer: cutoffs, procedures and safety , 2014, The New England journal of medicine.

[251]  G. Bruno,et al.  Hospital Admissions for Hypertensive Crisis in the Emergency Departments: A Large Multicenter Italian Study , 2014, PloS one.

[252]  M. Burnier,et al.  Improving Blood Pressure Control Through Pharmacist Interventions: A Meta‐Analysis of Randomized Controlled Trials , 2014, Journal of the American Heart Association.

[253]  M. Woodward,et al.  Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial , 2014, The Lancet Neurology.

[254]  Siegfried Wassertheurer,et al.  Moving on--on average in the right direction?: noninvasive methods to estimate central blood pressure. , 2014, Hypertension.

[255]  M. Pletcher,et al.  Early Adult to Midlife Cardiovascular Risk Factors and Cognitive Function , 2014, Circulation.

[256]  R. Grubb,et al.  Lower stroke risk with lower blood pressure in hemodynamic cerebral ischemia , 2014, Neurology.

[257]  J. Cutler,et al.  Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial , 2014, Diabetes Care.

[258]  Getachew Tegegne,et al.  Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[259]  S. Oparil,et al.  Refractory Hypertension: Determination of Prevalence, Risk Factors, and Comorbidities in a Large, Population-Based Cohort , 2014, Hypertension.

[260]  L. Køber,et al.  Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study. , 2014, JAMA internal medicine.

[261]  Ralph B D'Agostino,et al.  Stenting and medical therapy for atherosclerotic renal-artery stenosis. , 2014, The New England journal of medicine.

[262]  R. Därr,et al.  Phäochromozytom: Diagnostik und Therapie , 2014, Deutsche Medizinische Wochenschrift.

[263]  F. Hu,et al.  Long-Term Coffee Consumption and Risk of Cardiovascular Disease: A Systematic Review and a Dose–Response Meta-Analysis of Prospective Cohort Studies , 2014, Circulation.

[264]  D. Henderson-smart,et al.  Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. , 2014, The Cochrane database of systematic reviews.

[265]  Martin G Myers,et al.  Automated office blood pressure measurement in primary care. , 2014, Canadian family physician Medecin de famille canadien.

[266]  V. Feigin,et al.  Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010 , 2014, The Lancet.

[267]  K. Pillai,et al.  Assessment of nonsteroidal anti-inflammatory drug-induced cardiotoxicity , 2014, Expert opinion on drug metabolism & toxicology.

[268]  M. Brown,et al.  Is there a role for ambulatory blood pressure monitoring in pregnancy? , 2014, Clinical and experimental pharmacology & physiology.

[269]  A. AbuRahma,et al.  Renal imaging: duplex ultrasound, computed tomography angiography, magnetic resonance angiography, and angiography. , 2013, Seminars in vascular surgery.

[270]  G. Brabant,et al.  2013 ETA Guideline: Management of Subclinical Hypothyroidism , 2013, European Thyroid Journal.

[271]  P. Peduzzi,et al.  Combined angiotensin inhibition for the treatment of diabetic nephropathy. , 2013, The New England journal of medicine.

[272]  Jeroen J. Bax,et al.  2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. , 2013, European heart journal.

[273]  Henk A Marquering,et al.  Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. , 2013, European heart journal.

[274]  A. Napolitano,et al.  Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study. , 2013, Contraception.

[275]  R. Foley,et al.  High-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[276]  C. Otto,et al.  Time to treat hypertension in patients with aortic stenosis. , 2013, Circulation.

[277]  A. Da Silva,et al.  Beta blockers for peripheral arterial disease. , 2013, The Cochrane database of systematic reviews.

[278]  Martin McKee,et al.  Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. , 2013, JAMA.

[279]  R. Conwit,et al.  Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial , 2013, The Lancet.

[280]  H. Tighiouart,et al.  Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis , 2013, Canadian Medical Association Journal.

[281]  Bin Wang,et al.  Blood pressure‐lowering effects of GLP‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trials , 2013, Diabetes, obesity & metabolism.

[282]  J. Mayet,et al.  Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery , 2013, Heart.

[283]  Jeroen J. Bax,et al.  2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.

[284]  Michael Böhm,et al.  2013 ESH/ESC Guidelines for the management of arterial hypertension , 2007, Blood pressure.

[285]  M. Woodward,et al.  Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. , 2013, The New England journal of medicine.

[286]  D. Webb,et al.  A systematic review of the effect of paracetamol on blood pressure in hypertensive and non‐hypertensive subjects , 2013, British journal of clinical pharmacology.

[287]  A. Levin,et al.  Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. , 2013, Kidney international.

[288]  W. Henderson,et al.  Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. , 2013, JAMA.

[289]  G. MacGregor,et al.  Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials , 2013, BMJ : British Medical Journal.

[290]  Dolores Corella,et al.  Primary prevention of cardiovascular disease with a Mediterranean diet. , 2013, The New England journal of medicine.

[291]  S. Toennes,et al.  Resistant hypertension? Assessment of adherence by toxicological urine analysis , 2013, Journal of hypertension.

[292]  M. Gomes,et al.  Prevalence, Awareness, and Treatment of Hypertension in Patients with Type 1 Diabetes: A Nationwide Multicenter Study in Brazil , 2013, International journal of hypertension.

[293]  Jeffrey Perl,et al.  Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review. , 2013, The American journal of medicine.

[294]  A. Demchuk,et al.  The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial , 2013, Stroke.

[295]  M. Wintermark,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.

[296]  M. Järvelin,et al.  Elevated Blood Pressure in Pregnancy and Subsequent Chronic Disease Risk , 2013, Circulation.

[297]  V. Cornelissen,et al.  Exercise Training for Blood Pressure: A Systematic Review and Meta‐analysis , 2013, Journal of the American Heart Association.

[298]  H. Krum,et al.  Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. , 2012, Circulation.

[299]  M. Volpe,et al.  Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination. , 2012, Clinical drug investigation.

[300]  Nish Chaturvedi,et al.  Cardiorenal end points in a trial of aliskiren for type 2 diabetes. , 2012, The New England journal of medicine.

[301]  J. Cecatti,et al.  Physical exercise during pregnancy: a systematic review , 2012, Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia.

[302]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[303]  S. Yusuf,et al.  Ambulatory Blood Pressure Values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET) , 2012, Hypertension.

[304]  David C. Wheeler,et al.  Notice , 2012, Kidney International Supplements.

[305]  G. Carles,et al.  [Use of injectable urapidil in pregnancy-induced hypertension and preeclampsia]. , 2012, Journal de gynecologie, obstetrique et biologie de la reproduction.

[306]  R. Tal.  The Role of Hypoxia and Hypoxia-Inducible Factor-1Alpha in Preeclampsia Pathogenesis , 2012, Biology of reproduction.

[307]  D. Atar,et al.  ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .

[308]  D. Wald,et al.  Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. , 2012, The American journal of medicine.

[309]  C. A. Koch,et al.  11Beta-Hydroxylase Deficiency and Other Syndromes of Mineralocorticoid Excess as a Rare Cause of Endocrine Hypertension , 2012, Hormone and Metabolic Research.

[310]  W. Cushman,et al.  Diabetes and hypertension: the bad companions , 2012, The Lancet.

[311]  B. Capel,et al.  Macrophage-Mediated Regulation of the Spermatogonial Stem Cell Niche. , 2012 .

[312]  Siegfried Wassertheurer,et al.  Wave Reflections, Assessed With a Novel Method for Pulse Wave Separation, Are Associated With End-Organ Damage and Clinical Outcomes , 2012, Hypertension.

[313]  H. Parving,et al.  Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. , 2012, Kidney international.

[314]  R. Zweiker,et al.  Zeitgemäße Hochdruckdiagnose I: Ambulantes 24-Stunden-Blutdruckmonitoring , 2012 .

[315]  G. Stergiou,et al.  Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis , 2012, Journal of hypertension.

[316]  S. Daskalopoulou,et al.  The impact of physical activity on mortality in patients with high blood pressure: a systematic review , 2012, Journal of hypertension.

[317]  E. Staal,et al.  Hypertension in Aortic Stenosis: Implications for Left Ventricular Structure and Cardiovascular Events , 2012, Hypertension.

[318]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[319]  J. Mortimer.  The Nun Study: risk factors for pathology and clinical-pathologic correlations. , 2012, Current Alzheimer research.

[320]  D. Lawlor,et al.  Blood Pressure Change in Normotensive, Gestational Hypertensive, Preeclamptic, and Essential Hypertensive Pregnancies , 2012, Hypertension.

[321]  Jens Jordan,et al.  Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. , 2012, Journal of hypertension.

[322]  G. Lip,et al.  Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study , 2012, Journal of hypertension.

[323]  G. Zilleruelo,et al.  Hypertensive crisis in children , 2012, Pediatric Nephrology.

[324]  Heather M. Tavel,et al.  Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients , 2012, Circulation.

[325]  K. Eagle,et al.  Type-selective benefits of medications in treatment of acute aortic dissection (from the International Registry of Acute Aortic Dissection [IRAD]). , 2012, The American journal of cardiology.

[326]  N. Brown,et al.  Differential Effects of Nebivolol and Metoprolol on Insulin Sensitivity and Plasminogen Activator Inhibitor in the Metabolic Syndrome , 2012, Hypertension.

[327]  R. Krysiak,et al.  PRIMARY ALDOSTERONISM IN PREGNANCY , 2012, Acta clinica Belgica.

[328]  Obioha C Ukoumunne,et al.  Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis , 2012, The Lancet.

[329]  M. Böhm,et al.  Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. , 2012, Journal of the American College of Cardiology.

[330]  Carl Heneghan,et al.  Home measurement of blood pressure and cardiovascular disease: systematic review and meta-analysis of prospective studies , 2012, Journal of hypertension.

[331]  J. Filipovský,et al.  Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. , 2012, Journal of hypertension.

[332]  I. Chetter,et al.  Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials. , 2012, Atherosclerosis.

[333]  D. Sessler,et al.  Angiotensin Converting Enzyme Inhibitors Are Not Associated with Respiratory Complications or Mortality After Noncardiac Surgery , 2012, Anesthesia and analgesia.

[334]  A. Swaminathan,et al.  Effect of Antihypertensive Therapy on Incident Stroke in Cohorts With Prehypertensive Blood Pressure Levels: A Meta-Analysis of Randomized Controlled Trials , 2012, Stroke.

[335]  A. AbuRahma,et al.  Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period. , 2012, Journal of vascular surgery.

[336]  G. Reboldi,et al.  Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions. , 2012, Current drug safety.

[337]  Avis J. Thomas,et al.  Lifetime risks of cardiovascular disease. , 2012, The New England journal of medicine.

[338]  A. Hofman,et al.  Blood pressure tracking during pregnancy and the risk of gestational hypertensive disorders: the Generation R Study. , 2011, European heart journal.

[339]  P. Marik,et al.  Hypertensive emergencies: an update , 2011, Current opinion in critical care.

[340]  Salim Yusuf,et al.  Level of systolic blood pressure within the normal range and risk of recurrent stroke. , 2011, JAMA.

[341]  J. Martin,et al.  Births: final data for 2009. , 2011, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[342]  V. Gudnason,et al.  Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility--Reykjavik study. , 2011, Brain : a journal of neurology.

[343]  T. Pieber,et al.  Effects of a multifaceted educational program on blood pressure and cardiovascular risk in hypertensive patients: the Austrian herz.leben project , 2011, Journal of hypertension.

[344]  H. Makani,et al.  Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering syndrome. , 2011, European heart journal.

[345]  Edgardo Abalos,et al.  How to manage hypertension in pregnancy effectively. , 2011, British journal of clinical pharmacology.

[346]  T. Ogihara,et al.  Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial , 2011, Journal of hypertension.

[347]  S. Kanba,et al.  Midlife and Late-Life Blood Pressure and Dementia in Japanese Elderly: The Hisayama Study , 2011, Hypertension.

[348]  T. Weber,et al.  Association of increased arterial wave reflections with decline in renal function in chronic kidney disease stages 3 and 4. , 2011, American journal of hypertension.

[349]  Giuseppe Conte,et al.  Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. , 2011, Archives of internal medicine.

[350]  T. Wadden,et al.  Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes , 2011, Diabetes Care.

[351]  K. Pacak,et al.  Drugs and pheochromocytoma--don't be fooled by every elevated metanephrine. , 2011, The New England journal of medicine.

[352]  R. J. Valentine,et al.  Clinical and kidney morphologic predictors of outcome for renal artery stenting: data to inform patient selection. , 2011, Journal of vascular surgery.

[353]  G. V. van Montfrans,et al.  Endothelial dysfunction, platelet activation, thrombogenesis and fibrinolysis in patients with hypertensive crisis , 2011, Journal of hypertension.

[354]  M. Woodward,et al.  Meta-Analysis: Impact of Drug Class on Adherence to Antihypertensives , 2011, Circulation.

[355]  Eliseo Guallar,et al.  Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study , 2011, European heart journal.

[356]  H. Hense,et al.  Blood Pressure Percentiles by Age and Height From Nonoverweight Children and Adolescents in Germany , 2011, Pediatrics.

[357]  Rowena J Dolor,et al.  Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. , 2011, Journal of the American College of Cardiology.

[358]  Faha,et al.  Aha Guideline Effectiveness-based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update a Guideline from the American Heart Association Executive Writing Committee Expert Panel Members Cvd Risk Assessment Table 1. Class Iii Interventions (not Useful/effective and May Be Harmfu , 2022 .

[359]  G. Mancia,et al.  Better compliance to antihypertensive medications reduces cardiovascular risk , 2011, Journal of hypertension.

[360]  D. Jatužis,et al.  The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial , 2011, The Lancet.

[361]  P. Anyfanti,et al.  Hypertension and sexual dysfunction: time to act. , 2011, Journal of hypertension.

[362]  S. Laurent,et al.  Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients , 2010, Journal of hypertension.

[363]  R. Schmieder.  End organ damage in hypertension. , 2010, Deutsches Arzteblatt international.

[364]  Gregory Y H Lip,et al.  A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.

[365]  C. Dufouil,et al.  Long-term reduction in aortic stiffness: a 5.3-year follow-up in routine clinical practice , 2010, Journal of hypertension.

[366]  I. Hajjar,et al.  The relationship between blood pressure and cognitive function , 2010, Nature Reviews Cardiology.

[367]  A. Wallace,et al.  Association of the Pattern of Use of Perioperative &bgr;-Blockade and Postoperative Mortality , 2010, Anesthesiology.

[368]  A. Worsley,et al.  Influence of dietary modifications on the blood pressure response to antihypertensive medication , 2010, British Journal of Nutrition.

[369]  Rod S Taylor,et al.  Nurse led interventions to improve control of blood pressure in people with hypertension: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[370]  C. Bulpitt,et al.  Effects of antihypertensive treatment after acute stroke in the Continue Or Stop post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial , 2010, The Lancet Neurology.

[371]  Richard J McManus,et al.  Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial , 2010, The Lancet.

[372]  S. Yusuf,et al.  Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study , 2010, The Lancet.

[373]  G. Bakris,et al.  Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. , 2010, JAMA.

[374]  R. Fagard,et al.  Orthostatic Hypotension Is a More Robust Predictor of Cardiovascular Events Than Nighttime Reverse Dipping in Elderly , 2010, Hypertension.

[375]  G. Mancia,et al.  Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice , 2010, Journal of hypertension.

[376]  L. Trinquart,et al.  Efficacy of Revascularization For Renal Artery Stenosis Caused by Fibromuscular Dysplasia: A Systematic Review and Meta-Analysis , 2010, Hypertension.

[377]  F. Cuccurullo,et al.  RELATIONSHIP BETWEEN METABOLIC SYNDROME AND LEFT VENTRICULAR REMODELING: INFLUENCE OF GENDER: PP.22.356 , 2010, American journal of hypertension.

[378]  G. Soulez,et al.  Renal artery revascularization: predictive value of kidney length and volume weighted by resistive index. , 2010, AJR. American journal of roentgenology.

[379]  Kevin A Peterson,et al.  Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .

[380]  Eric Boerwinkle,et al.  Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. , 2010, Journal of the American College of Cardiology.

[381]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[382]  T. Hansen,et al.  Risk prediction is improved by adding markers of subclinical organ damage to SCORE. , 2010, European heart journal.

[383]  J. V. van Roosmalen,et al.  Rise in maternal mortality in the Netherlands , 2010, BJOG : an international journal of obstetrics and gynaecology.

[384]  A. Stanson,et al.  Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[385]  Martin G Myers,et al.  Measurement of blood pressure in the office: recognizing the problem and proposing the solution. , 2010, Hypertension.

[386]  N. Poulter,et al.  Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents: A Meta-Analysis , 2010, Hypertension.

[387]  C. Reid,et al.  Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis , 2009, Journal of hypertension.

[388]  B. Davis,et al.  Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). , 2009, Journal of the American College of Cardiology.

[389]  C. Baigent,et al.  Revascularization versus medical therapy for renal-artery stenosis. , 2009, The New England journal of medicine.

[390]  G. Panjrath,et al.  The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential? , 2009, Journal of the American College of Cardiology.

[391]  G. Lip,et al.  Improving survival of malignant hypertension patients over 40 years. , 2009, American journal of hypertension.

[392]  L. Thijs,et al.  Regression of Left Ventricular Mass by Antihypertensive Treatment: A Meta-Analysis of Randomized Comparative Studies , 2009, Hypertension.

[393]  Li-sheng Liu,et al.  Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature , 2009, Hypertension Research.

[394]  A. Anarat,et al.  Strict blood-pressure control and progression of renal failure in children. , 2009, The New England journal of medicine.

[395]  M. Maitland,et al.  Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment , 2009, Clinical Cancer Research.

[396]  G. Parati,et al.  Baseline Values but Not Treatment-Induced Changes in Carotid Intima-Media Thickness Predict Incident Cardiovascular Events in Treated Hypertensive Patients: Findings in the European Lacidipine Study on Atherosclerosis (ELSA) , 2009, Circulation.

[397]  S. Oparil,et al.  Effects of Dietary Sodium Reduction on Blood Pressure in Subjects With Resistant Hypertension: Results From a Randomized Trial , 2009, Hypertension.

[398]  J. Staessen,et al.  Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial , 2009, The Lancet.

[399]  M. Stampfer,et al.  Diet and lifestyle risk factors associated with incident hypertension in women. , 2009, JAMA.

[400]  A. Webster,et al.  Antihypertensives for Kidney Transplant Recipients: Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2009, Transplantation.

[401]  M. Kaste,et al.  Relationship of Blood Pressure, Antihypertensive Therapy, and Outcome in Ischemic Stroke Treated With Intravenous Thrombolysis: Retrospective Analysis From Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR) , 2009, Stroke.

[402]  W. Mali,et al.  Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. , 2009, Annals of internal medicine.

[403]  J. Auer,et al.  Pheochromocytoma crisis presenting with shock and tako-tsubo-like cardiomyopathy. , 2009, International journal of cardiology.

[404]  N J Wald,et al.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies , 2009, BMJ : British Medical Journal.

[405]  B. Davis,et al.  ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. , 2009, Archives of internal medicine.

[406]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[407]  J. Soria,et al.  Review Management of Hypertension in Angiogenesis Inhibitor-treated Patients , 2022 .

[408]  M. Esler,et al.  Sympathetic activation in chronic renal failure. , 2009, Journal of the American Society of Nephrology : JASN.

[409]  J. Engvall,et al.  Masked nocturnal hypertension—a novel marker of risk in type 2 diabetes , 2009, Diabetologia.

[410]  G. Stergiou,et al.  Long-term reproducibility of home vs. office blood pressure in children and adolescents: the Arsakeion school study , 2009, Hypertension Research.

[411]  F. Zitman,et al.  Depression Is Associated With Decreased Blood Pressure, but Antidepressant Use Increases the Risk for Hypertension , 2009, Hypertension.

[412]  C. Cannon,et al.  Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study , 2009, Journal of hypertension.

[413]  T. LeCompte,et al.  Vascular Structure and Function Is Correlated to Cognitive Performance and White Matter Hyperintensities in Older Hypertensive Patients With Subjective Memory Complaints , 2009, Stroke.

[414]  D. Grobbee,et al.  Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials , 2009, The Lancet.

[415]  D. Wald,et al.  Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials , 2010 .

[416]  J. Bilezikian,et al.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. , 2009, The Journal of clinical endocrinology and metabolism.

[417]  H. Hulter,et al.  Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA). , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[418]  Carol Jagger,et al.  Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial , 2009, The Lancet Neurology.

[419]  K. Stergiopoulos,et al.  Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: Systematic review and meta-analysis , 2009, Acta oncologica.

[420]  G. Bakris,et al.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. , 2008, The New England journal of medicine.

[421]  H. Joensuu,et al.  Hypertension and clinical benefit of bevacizumab in the treatment of advanced renal cell carcinoma. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[422]  T. Lumley,et al.  Blood pressure control and risk of incident atrial fibrillation. , 2008, American journal of hypertension.

[423]  M. Newman,et al.  The ECLIPSE Trials: Comparative Studies of Clevidipine to Nitroglycerin, Sodium Nitroprusside, and Nicardipine for Acute Hypertension Treatment in Cardiac Surgery Patients , 2008, Anesthesia and analgesia.

[424]  P. Gosse,et al.  Ambulatory blood pressure monitoring versus self-measurement of blood pressure at home: correlation with target organ damage , 2008, Journal of hypertension.

[425]  A. Garg,et al.  Angiotensin inhibition in renovascular disease: a population-based cohort study. , 2008, American heart journal.

[426]  S. Yusuf,et al.  Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial , 2008, The Lancet.

[427]  R. Bache,et al.  Regulation of coronary blood flow during exercise. , 2008, Physiological reviews.

[428]  Furman S. McDonald,et al.  Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period. , 2008, Journal of hospital medicine.

[429]  Youfa Wang,et al.  Tracking of Blood Pressure From Childhood to Adulthood: A Systematic Review and Meta–Regression Analysis , 2008, Circulation.

[430]  D. Goff,et al.  Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. , 2008, Circulation.

[431]  D. Singer,et al.  Management of hypertension in peripheral arterial disease: does the choice of drugs matter? , 2008, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[432]  T. Zeller,et al.  Color‐coded duplex ultrasound for diagnosis of renal artery stenosis and as follow‐up examination after revascularization , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[433]  W. Zidek,et al.  Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[434]  G. Navis,et al.  Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. , 2008, Journal of the American Society of Nephrology : JASN.

[435]  V. Montori,et al.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[436]  Li-sheng Liu,et al.  Treatment of hypertension in patients 80 years of age or older. , 2008, The New England journal of medicine.

[437]  J. Cohn,et al.  Effect of Baseline and Changes in Systolic Blood Pressure Over Time on the Effectiveness of Valsartan in the Valsartan Heart Failure Trial , 2008, Circulation. Heart failure.

[438]  V. Musini,et al.  Pharmacological interventions for hypertensive emergencies: a Cochrane systematic review , 2008, Journal of Human Hypertension.

[439]  S. Yusuf,et al.  Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.

[440]  S. Textor.  Atherosclerotic renal artery stenosis: overtreated but underrated? , 2008, Journal of the American Society of Nephrology : JASN.

[441]  A. Laggner,et al.  Association between hypertensive urgencies and subsequent cardiovascular events in patients with hypertension , 2008, Journal of hypertension.

[442]  L. Poston,et al.  Adverse Perinatal Outcomes and Risk Factors for Preeclampsia in Women With Chronic Hypertension: A Prospective Study , 2008, Hypertension.

[443]  P. Ouyang,et al.  Menopause and hypertension: an age-old debate. , 2008, Hypertension.

[444]  T. Yamanaka,et al.  Exaggerated Hypertensive Response to Exercise in Patients with Diastolic Heart Failure , 2008, Hypertension Research.

[445]  G. Mancia,et al.  Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy , 2008, Journal of Hypertension.

[446]  A. Kudelka,et al.  Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis. , 2008, The Lancet. Oncology.

[447]  B. Davis,et al.  Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2008, Archives of internal medicine.

[448]  C. Porta,et al.  Uncovering Pandora’s vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib , 2007, Clinical and Experimental Medicine.

[449]  F. Veglio,et al.  Antihypertensive Drugs and the Sympathetic Nervous System , 2007, Journal of cardiovascular pharmacology.

[450]  H. Okayama,et al.  Possible link between large artery stiffness and coronary flow velocity reserve , 2007, Heart.

[451]  Anushka Patel,et al.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial , 2007, The Lancet.

[452]  M. Nieminen,et al.  Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy and Reduction in Sudden Cardiac Death: The LIFE Study , 2007, Circulation.

[453]  Mary S. Lee,et al.  Prevention of Erythropoietin-Associated Hypertension , 2007, Hypertension.

[454]  M. O'Rourke,et al.  Mechanical factors in arterial aging: a clinical perspective. , 2007, Journal of the American College of Cardiology.

[455]  M. Mori,et al.  Association of ambulatory use of statins and beta-blockers with long-term mortality after vascular surgery. , 2007, Journal of hospital medicine.

[456]  V. Garovic,et al.  Hypertensive Pregnancy Disorders: Current Concepts , 2007, Journal of clinical hypertension.

[457]  T. Turan,et al.  Relationship Between Blood Pressure and Stroke Recurrence in Patients With Intracranial Arterial Stenosis , 2007, Circulation.

[458]  Michael Böhm,et al.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.

[459]  L. Dirix,et al.  Treatment of arterial hypertension (AHT) associated with angiogenesis inhibitors. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[460]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[461]  D. Kent,et al.  Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. , 2007, Journal of the American Society of Nephrology : JASN.

[462]  H. Izzedine,et al.  Hypertension as a predictive factor of Sunitinib activity. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[463]  Cherylyn Beckey,et al.  Lercanidipine in the Treatment of Hypertension , 2007, The Annals of pharmacotherapy.

[464]  J. Craig,et al.  Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis. , 2007, AJR. American journal of roentgenology.

[465]  W. Dahut,et al.  Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[466]  R. Stafford,et al.  Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. , 2007, Archives of internal medicine.

[467]  Apurva A Desai,et al.  Sorafenib in advanced clear-cell renal-cell carcinoma. , 2007, The New England journal of medicine.

[468]  M. Esler,et al.  Sympathetic Activity in Major Depressive Disorder: Identifying Those at Increased Cardiac Risk? , 2007, Journal of hypertension.

[469]  D. Laude,et al.  Specific Serotonin Reuptake Inhibition in Major Depressive Disorder Adversely Affects Novel Markers of Cardiac Risk , 2007, Hypertension Research.

[470]  M. Salvetti,et al.  European Society of Hypertension Scientific Newsletter: Treatment of hypertensive urgencies and emergencies , 2006, Journal of hypertension.

[471]  Ganesh Manoharan,et al.  Assessment of renal artery stenosis severity by pressure gradient measurements. , 2006, Journal of the American College of Cardiology.

[472]  H. Struijker‐Boudier,et al.  Expert consensus document on arterial stiffness: methodological issues and clinical applications. , 2006, European heart journal.

[473]  Eduardo Lacson,et al.  The epidemiology of systolic blood pressure and death risk in hemodialysis patients. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[474]  S. Solomon,et al.  Effect of Celecoxib on Cardiovascular Events and Blood Pressure in Two Trials for the Prevention of Colorectal Adenomas , 2006, Circulation.

[475]  S. Heffelfinger,et al.  Potential deployment of angiotensin I converting enzyme inhibitors and of angiotensin II type 1 and type 2 receptor blockers in cancer chemotherapy. , 2006, Anti-cancer agents in medicinal chemistry.

[476]  S. Yusuf,et al.  Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials , 2006, The Lancet.

[477]  G. Bakris,et al.  Thiazide Diuretics, Potassium, and the Development of Diabetes: A Quantitative Review , 2006, Hypertension.

[478]  H. Hopp,et al.  Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil. , 2006, European journal of obstetrics, gynecology, and reproductive biology.

[479]  J. Staessen,et al.  Carotid Intima-Media Thickness and Antihypertensive Treatment: A Meta-Analysis of Randomized Controlled Trials , 2006, Stroke.

[480]  M. Woodward,et al.  Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial , 2006, Journal of hypertension.

[481]  Ira Tabas,et al.  Letter by Williams and Tabas regarding article "atherosclerosis 2005: recent discoveries and novel hypotheses". , 2006, Circulation.

[482]  J. Foster,et al.  Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. , 2006, Kidney international.

[483]  R. Sacco,et al.  Recurrent stroke and cardiac risks after first ischemic stroke , 2006, Neurology.

[484]  Alice Stanton,et al.  Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes: Principal Results of the Conduit Artery Function Evaluation (CAFE) Study , 2006, Circulation.

[485]  G. Heinze,et al.  Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. , 2006, Journal of the American Society of Nephrology : JASN.

[486]  A. Cheung.  Exploring an Optimum Intra/Postoperative Management Strategy for Acute Hypertension in the Cardiac Surgery Patient , 2006, Journal of cardiac surgery.

[487]  Rodney A. White,et al.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography , 2006, Circulation.

[488]  Rodney A. White,et al.  ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Ang , 2006, Journal of the American College of Cardiology.

[489]  I. Meredith,et al.  Aortic stiffness affects the coronary blood flow response to percutaneous coronary intervention. , 2006, American journal of physiology. Heart and circulatory physiology.

[490]  R. Qayyum,et al.  A Meta‐Analysis of the Effect of Thiazolidinediones on Blood Pressure , 2006, Journal of clinical hypertension.

[491]  G. Opelz,et al.  Improved Long‐Term Outcomes After Renal Transplantation Associated with Blood Pressure Control , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[492]  R. Toto,et al.  Treatment of hypertension in chronic kidney disease. , 2005, Seminars in nephrology.

[493]  A. Evangelista,et al.  Long-term vasodilator therapy in patients with severe aortic regurgitation. , 2005, The New England journal of medicine.

[494]  R. Collins,et al.  Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled tri , 2005, The Lancet.

[495]  W. März,et al.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005, The New England journal of medicine.

[496]  S. Yusuf,et al.  Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis , 2005 .

[497]  F. Fuchs,et al.  Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension , 2005, Journal of Human Hypertension.

[498]  Barry R. Davis,et al.  Outcomes in Hypertensive Black and Nonblack Patients Treated With Chlorthalidone, Amlodipine, and Lisinopril , 2005 .

[499]  J. Passauer,et al.  Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide. , 2005, Journal of the American Society of Nephrology : JASN.

[500]  Daniel W. Jones,et al.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. , 2005, Hypertension.

[501]  P. Raskin,et al.  Metabolic effects of carvedilol vs. metoprolol in patients with type 2 diabetes mellitus and hypertension: A randomized controlled trial , 2005 .

[502]  K. Adams,et al.  Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, American heart journal.

[503]  M. Nieminen,et al.  Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study , 2005, Hypertension.

[504]  S. Miura,et al.  Nifedipine-Induced Vascular Endothelial Growth Factor Secretion from Coronary Smooth Muscle Cells Promotes Endothelial Tube Formation via the Kinase Insert Domain-Containing Receptor/Fetal Liver Kinase-1/NO Pathway , 2005, Hypertension Research.

[505]  G. Mancia,et al.  Different Effects of Antihypertensive Regimens Based on Fosinopril or Hydrochlorothiazide With or Without Lipid Lowering by Pravastatin on Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of PHYLLIS—A Randomized Double-Blind Trial , 2004, Stroke.

[506]  M. Nieminen,et al.  Prognostic significance of left ventricular mass change during treatment of hypertension. , 2004, JAMA.

[507]  C. Nelson-Piercy,et al.  Management of hypertension before, during, and after pregnancy , 2004, Heart.

[508]  P. Raskin,et al.  Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. , 2004, JAMA.

[509]  P. Libby,et al.  Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure The CAMELOT Study: A Randomized Controlled Trial , 2004 .

[510]  D. Panagiotakos,et al.  Smoking and caffeine have a synergistic detrimental effect on aortic stiffness and wave reflections. , 2004, Journal of the American College of Cardiology.

[511]  P. Torjesen,et al.  Low-renin status in therapy-resistant hypertension: a clue to efficient treatment , 2004, Journal of hypertension.

[512]  H. Kraemer,et al.  Nurse management for hypertension. A systems approach. , 2004, American journal of hypertension.

[513]  T. Murphy,et al.  Increase in utilization of percutaneous renal artery interventions by medicare beneficiaries, 1996-2000. , 2004, AJR. American journal of roentgenology.

[514]  Jaclyn Leblanc,et al.  Acute postoperative hypertension: a review of therapeutic options. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[515]  B. Rosner,et al.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents , 2004 .

[516]  J. Gardin,et al.  Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study. , 2004, Journal of the American College of Cardiology.

[517]  P. Blankestijn,et al.  Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. , 2004, Kidney international.

[518]  J. Rouleau,et al.  Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. , 2004, Journal of the American College of Cardiology.

[519]  C. Otto,et al.  Hemodynamic Effects of the Angiotensin-Converting Enzyme Inhibitor, Ramipril, in Patients with Mild to Moderate Aortic Stenosis and Preserved Left Ventricular Function , 2004, Journal of Investigative Medicine.

[520]  Richard J. Johnson,et al.  Hypertension in the hemodialysis patient and the "lag phenomenon": insights into pathophysiology and clinical management. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[521]  R Alagesan,et al.  Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS). , 2004, American heart journal.

[522]  G. Schernthaner,et al.  Klassifikation, Diagnostik und Therapie der Hypertonie 2007 - Empfehlungen der Österreichischen Gesellschaft für Hypertensiologie , 2004 .

[523]  F. Schaefer,et al.  Home, Clinic, and Ambulatory Blood Pressure Monitoring in Children with Chronic Renal Failure , 2004, Pediatric Research.

[524]  S. Hussain.  Progestogen-only pills and high blood pressure: is there an association? A literature review. , 2004, Contraception.

[525]  M. Esler,et al.  Sympathetic Augmentation in Hypertension: Role of Nerve Firing, Norepinephrine Reuptake, and Angiotensin Neuromodulation , 2004, Hypertension.

[526]  P. Rothwell,et al.  Relationship Between Blood Pressure and Stroke Risk in Patients With Symptomatic Carotid Occlusive Disease , 2003, Stroke.

[527]  Diederick E. Grobbee,et al.  Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials , 2003, Hypertension.

[528]  L. Magee,et al.  Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis , 2003, BMJ : British Medical Journal.

[529]  Christopher H Schmid,et al.  Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis , 2003, Annals of Internal Medicine.

[530]  N J Wald,et al.  Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials , 2003, BMJ : British Medical Journal.

[531]  V. Vallyathan,et al.  Hydroxyl radical formation is greater in striatal core than in penumbra in a rat model of ischemic stroke , 2003, Journal of neuroscience research.

[532]  B. Davis,et al.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.

[533]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[534]  J. Nürnberger,et al.  Augmentation index is associated with cardiovascular risk , 2002, Journal of hypertension.

[535]  J. Morales.  Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation. , 2002, Kidney international. Supplement.

[536]  Tom Greene,et al.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.

[537]  R. North,et al.  Use of automated home blood pressure monitoring in pregnancy: is it safe? , 2002, American journal of obstetrics and gynecology.

[538]  G. MacGregor,et al.  Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health , 2002, Journal of Human Hypertension.

[539]  J. Graves.  Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. , 2002, Journal of hypertension.

[540]  James D Cameron,et al.  Large artery stiffness predicts ischemic threshold in patients with coronary artery disease. , 2002, Journal of the American College of Cardiology.

[541]  K. Eagle,et al.  Acute type A aortic dissection in the elderly: clinical characteristics, management, and outcomes in the current era. , 2002, Journal of the American College of Cardiology.

[542]  Jiang He,et al.  Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. , 2002, The American journal of clinical nutrition.

[543]  J. Tijssen,et al.  Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. , 2002, Clinical radiology.

[544]  Jiang He,et al.  Effect of Aerobic Exercise on Blood Pressure , 2002, Annals of Internal Medicine.

[545]  C. Vlachopoulos,et al.  Caffeine increases aortic stiffness in hypertensive patients. , 2002, American journal of hypertension.

[546]  D. Holmes,et al.  Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. , 2002, Mayo Clinic proceedings.

[547]  W. Frishman.  Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema. , 2002, The American journal of cardiology.

[548]  روشنک حسن زهرایی,et al.  ارزیابی عوامل مرتبط با اختلال روابط زناشویی در دوران بارداری , 2002 .

[549]  K. Rootwelt,et al.  Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril. , 2001, Transplantation.

[550]  C. Dudley.  Treatment of posttranplant hypertension: ACE is trumped? , 2001, Transplantation.

[551]  R. Agarwal,et al.  Lisinopril therapy for hemodialysis hypertension: hemodynamic and endocrine responses. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[552]  R. Cífková,et al.  Cyclosporin-induced hypertension. , 2001, Journal of hypertension.

[553]  C. Nappi,et al.  Effects of hormonal replacement therapy in postmenopausal hypertensive patients. , 2001, Maturitas.

[554]  D. Mark,et al.  Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. , 2001, Kidney international.

[555]  Hsiu-Ching Hsu,et al.  Hypertension Status Is the Major Determinant of Carotid Atherosclerosis: A Community-Based Study in Taiwan , 2001, Stroke.

[556]  M. Woodward,et al.  Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .

[557]  E. Lewis,et al.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.

[558]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[559]  I. Ingemarsson,et al.  Blood pressure during pregnancy in a Swedish population; impact of parity , 2001, Acta obstetricia et gynecologica Scandinavica.

[560]  S. Yusuf,et al.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. , 2001, JAMA.

[561]  A. Nicolaides,et al.  Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study) , 2001 .

[562]  S. Howell,et al.  Survey of cancellation rate of hypertensive patients undergoing anaesthesia and elective surgery. , 2001, British journal of anaesthesia.

[563]  Alan C. Wilson,et al.  Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). , 2001, Archives of internal medicine.

[564]  Martin G. Larson,et al.  Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change With Aging?: The Framingham Heart Study , 2001, Circulation.

[565]  J. Blacher,et al.  Impact of Aortic Stiffness Attenuation on Survival of Patients in End-Stage Renal Failure , 2001, Circulation.

[566]  M Galanski,et al.  Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. , 2001, The New England journal of medicine.

[567]  Emanuela Falaschetti,et al.  Association Between Smoking and Blood Pressure: Evidence From the Health Survey for England , 2001, Hypertension.

[568]  N. Milas,et al.  Long-Term Weight Loss and Changes in Blood Pressure: Results of the Trials of Hypertension Prevention, Phase II , 2001, Annals of Internal Medicine.

[569]  H. Parving,et al.  Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy. , 2000, Diabetes care.

[570]  N. Wahlgren,et al.  Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. , 2000, Stroke.

[571]  Barry R. Davis,et al.  Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. , 2000, JAMA.

[572]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[573]  P A Poole-Wilson,et al.  Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. , 1999, Circulation.

[574]  A W Halligan,et al.  Comparison of auscultatory and oscillometric automated blood pressure monitors in the setting of preeclampsia. , 1999, American journal of obstetrics and gynecology.

[575]  D. Levy,et al.  Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. , 1999, Circulation.

[576]  G. Bellomo,et al.  Prognostic value of 24-hour blood pressure in pregnancy. , 1999, JAMA.

[577]  R J Glynn,et al.  Increased pulse pressure and risk of heart failure in the elderly. , 1999, JAMA.

[578]  D. Levy,et al.  Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. , 1998, Journal of the American College of Cardiology.

[579]  M. Thase.  Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. , 1998, The Journal of clinical psychiatry.

[580]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[581]  R. Holman,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .

[582]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[583]  J. Mullins,et al.  Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27 , 1998, Journal of hypertension.

[584]  P. Whelton,et al.  Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. , 1998, JAMA.

[585]  David R. Jones,et al.  Automated, ambulatory, or conventional blood pressure measurement in pregnancy: Which is the better predictor of severe hypertension? ☆ ☆☆ ★ ★★ , 1998 .

[586]  J. Polónia,et al.  Low‐dose oral contraceptives and 24‐hour ambulatory blood pressure , 1997, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[587]  Anthony Johnson,et al.  NSAIDs and Increased Blood Pressure , 1997, Drug safety.

[588]  G. Rosenbusch,et al.  Magnetic resonance angiography has a high reliability in the detection of renal artery stenosis. , 1997, American journal of hypertension.

[589]  J. Cohn,et al.  Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group. , 1997, Circulation.

[590]  M. Müllner,et al.  Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies , 1997, Intensive Care Medicine.

[591]  B. Davis,et al.  Prevention of Heart Failure by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension , 1997 .

[592]  D. Levy,et al.  Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. , 1997, Circulation.

[593]  T. Lüscher,et al.  Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: role of pharmacokinetics. , 1997, Journal of the American College of Cardiology.

[594]  P. Whelton,et al.  Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. , 1997, JAMA.

[595]  G. Bray,et al.  A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. , 1997, The New England journal of medicine.

[596]  R. Berg,et al.  Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[597]  K. Adams,et al.  Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. , 1996, Circulation.

[598]  C M O'Connor,et al.  Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. , 1996, The New England journal of medicine.

[599]  J. Manson,et al.  Prospective study of oral contraceptives and hypertension among women in the United States. , 1996, Circulation.

[600]  M. Prokop,et al.  Spiral CT angiography--can we forget about arteriography to diagnose renal artery stenosis? , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[601]  B. Julian,et al.  Amlodipine increases cyclosporine levels in hypertensive renal transplant patients: results of a prospective study. , 1996, Journal of the American Society of Nephrology : JASN.

[602]  P. Elliott,et al.  Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations , 1996 .

[603]  T. Lüscher,et al.  [Controversy over calcium antagonists: is there a rationally differentiating therapy?]. , 1996, Deutsche medizinische Wochenschrift.

[604]  Furberg Cd,et al.  Corrections to the nifedipine meta-analysis. , 1996 .

[605]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[606]  M. Hirschl.  Guidelines for the Drug Treatment of Hypertensive Crises , 1995, Drugs.

[607]  B. Psaty,et al.  Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. , 1995, Circulation.

[608]  J. Whitworth,et al.  Ambulatory blood pressure in pregnancy: comparison of the Spacelabs 90207 and Accutracker II monitors with intraarterial recordings. , 1995, American journal of obstetrics and gynecology.

[609]  J. Foidart,et al.  Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. , 1995, The Journal of clinical endocrinology and metabolism.

[610]  M. Lefkowitz,et al.  The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil. , 1995, Archives of internal medicine.

[611]  N. Kaplan,et al.  Management of hypertensive emergencies , 1994, The Lancet.

[612]  A. Bellucci,et al.  Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[613]  T. Raghunathan,et al.  Diuretic therapy for hypertension and the risk of primary cardiac arrest. , 1994, The New England journal of medicine.

[614]  E. Murphy,et al.  Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. , 1994, The New England journal of medicine.

[615]  N. Vaziri,et al.  Effect of erythrocyte mass on arterial blood pressure in dialysis patients receiving maintenance erythropoietin therapy. , 1994, Journal of the American Society of Nephrology : JASN.

[616]  M. Alderman,et al.  Role of Preclinical Cardiovascular Disease in the Evolution From Risk Factor Exposure to Development of Morbid Events , 1993, Circulation.

[617]  F. Mee,et al.  Twenty-four-hour ambulatory blood pressure measurement in a primigravid population , 1993, Journal of hypertension.

[618]  C. Ashley,et al.  Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure. , 1993, Kidney international.

[619]  R. Converse,et al.  Sympathetic overactivity in patients with chronic renal failure. , 1992, The New England journal of medicine.

[620]  G. Parati,et al.  Persistent blood pressure increase induced by heavy smoking. , 1992, Journal of hypertension.

[621]  J. Whisnant,et al.  Hypertension and the brain. The National High Blood Pressure Education Program. , 1992, Archives of internal medicine.

[622]  K. Radack,et al.  Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. , 1991, Archives of internal medicine.

[623]  M. Houston,et al.  Nonsteroidal anti-inflammatory drugs and antihypertensives. , 1991, The American journal of medicine.

[624]  D. Martin,et al.  Sodium handling by deep nephrons and the terminal collecting duct in glomerulonephritis. , 1991, Kidney international.

[625]  E. Rimm,et al.  A Prospective Study of Nutritional Factors and Hypertension Among US Men , 1989, Circulation.

[626]  J. Gold,et al.  The preoperative and intraoperative hemodynamic predictors of postoperative myocardial infarction or ischemia in patients undergoing noncardiac surgery. , 1989, Annals of surgery.

[627]  O. Paulson,et al.  Cerebral blood flow and its pathophysiology in hypertension. , 1989, American journal of hypertension.

[628]  D. Levy,et al.  Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. , 1987, The American journal of cardiology.

[629]  B. Sibai,et al.  Effects of diuretics on plasma volume in pregnancies with long-term hypertension. , 1984, American journal of obstetrics and gynecology.

[630]  J. Sowers,et al.  The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. , 1981, The New England journal of medicine.

[631]  C. Bloor,et al.  Characteristics of coronary blood flow and transmural distribution in miniature pigs. , 1978, The American journal of physiology.

[632]  E. Chester,et al.  Hypertensive encephalopathy , 1978, Neurology.

[633]  T. Kearns,et al.  Prognostic importance of ophthalmoscopic findings in essential hypertension. , 1966, Journal of the American Medical Association (JAMA).

[634]  Perera Ga.  Hypertension; a manifestation of hypertensive vascular disease. , 1948 .

[635]  S. Caselli,et al.  High blood pressure response to exercise predicts future development of hypertension in young athletes , 2018, European heart journal.

[636]  B. Carlberg,et al.  Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis , 2018, JAMA internal medicine.

[637]  C. Zoccali,et al.  Office, standardized and 24-h ambulatory blood pressure and renal function loss in renal transplant patients , 2018, Journal of hypertension.

[638]  G. Curhan,et al.  Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. , 2018, The lancet. Diabetes & endocrinology.

[639]  A Ross Naylor,et al.  2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed b , 2018, European heart journal.

[640]  Fiorenzo Gaita,et al.  Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. , 2018, The lancet. Diabetes & endocrinology.

[641]  S. Textor.  Renal Arterial Disease and Hypertension. , 2017, The Medical clinics of North America.

[642]  Mahboob Rahman,et al.  Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study , 2017, Hypertension.

[643]  A. Hoes,et al.  2016 European Guidelines on cardiovascular disease prevention in clinical practice. , 2016, Revista espanola de cardiologia.

[644]  V. Aboyans,et al.  [2014 ESC Guidelines on the diagnosis and treatment of aortic diseases]. , 2014, Kardiologia polska.

[645]  V. Chair,et al.  Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.

[646]  F. Messerli,et al.  Drug-induced hypertension: an unappreciated cause of secondary hypertension. , 2012, The American journal of medicine.

[647]  Jeroen J. Bax,et al.  Increase of 1-year mortality after perioperative beta-blocker withdrawal in endovascular and vascular surgery patients. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[648]  M. Joffe,et al.  Blood pressure and the survival of renal allografts from living donors. , 2004, Journal of the American Society of Nephrology : JASN.

[649]  G. Hitzenberger,et al.  Blood pressure characteristics of hypertensive patients in Austria as determined by self-monitoring (SCREEN-II). , 2003 .

[650]  D. Malone,et al.  The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents. , 2003, Clinical therapeutics.

[651]  S. Kimmel,et al.  Perioperative β-blocker withdrawal and mortality in vascular surgical patients , 2001 .

[652]  J. Moutquin,et al.  The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). , 2001 .

[653]  L. Jensen,et al.  Pharmacokinetic interaction between cyclosporine and the dihydropyridine calcium antagonist felodipine , 1996, European Journal of Clinical Pharmacology.

[654]  G. Bastert,et al.  [Anti-hypertensive therapy in pregnancy-induced hypertension with urapidil]. , 1994, Zentralblatt fur Gynakologie.

[655]  A. J. Man in't veld,et al.  Do beta-blockers really increase peripheral vascular resistance? Review of the literature and new observations under basal conditions. , 1988, American journal of hypertension.